SOLV
Ticker
Solventum Corp
Company
Devices
Industry
Healthcare
Sector
Financial Ratio Analysis
2021
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”-0.5%0.8%0.7%β€”2.3%
Revenue Growth QoQ
β€”-0.5%0.8%0.7%β€”β€”
Gross Margin
60.2%57.7%57.3%55.6%β€”54.1%
EBITDA Margin
30.3%27.9%27.5%19.3%β€”32.3%
Operating Margin
23.0%20.8%20.6%12.6%β€”26.1%
Profit Margin
17.9%16.5%16.4%5.8%β€”18.1%
FCF / EBITDA
77.7%62.9%72.1%50.6%β€”1.8%